Search
Ridogrel
go.drugbank.com/drugs/DB01207ExperimentalHowever, there currently are no clinical indications for preferential use of ridogrel over aspirin. … Ridogrel is a dual action drug useful for the prevention of systemic thrombo-embolism and as an adjunctive agent to thrombolytic therapy in acute myocardial infarction.
Darusentan
go.drugbank.com/drugs/DB04883InvestigationalIt is being evaluated as a treatment for congestive heart failure and hypertension.
KD3010
go.drugbank.com/drugs/DB05188ExperimentalKD3010 is a small molecule peroxisome proliferator-activator receptor delta (PPAR Delta) agonist for the treatment of metabolic disorders, including obesity.
ADX-10061
go.drugbank.com/drugs/DB05419ExperimentalIt is developed by Addex Pharmaceuticals for the treatment of nicotine dependence.
SPP1148
go.drugbank.com/drugs/DB05203ExperimentalSPP1148, the most promising compound from a new series of renin inhibitors for the treatment of hypertension and related end-organ disease.
Ciclesonide
go.drugbank.com/drugs/DB01410ApprovedInvestigationalCiclesonide is a glucocorticoid used to treat obstructive airway diseases. It is marketed under the brand name Alvesco.
Categories: Drugs for Obstructive Airway DiseasesRiltozinameran
go.drugbank.com/drugs/DB17095ApprovedInvestigationalIt is administered in combination with [tozinameran] for active immunization against COVID-19 caused by SARS-CoV-2, including infection caused by Omicron BA.1[L45419]
E-6201
go.drugbank.com/drugs/DB11687InvestigationalE6201 has been investigated for the treatment of Chronic Plaque Psoriasis.
Vonapanitase
go.drugbank.com/drugs/DB11690InvestigationalVonapanitase is under investigation for the treatment of Chronic Kidney Disease.
Tegobuvir
go.drugbank.com/drugs/DB11852InvestigationalTegobuvir has been investigated for the treatment of Hepatitis C, Chronic.